September/October 2019

The U.S. now will allow  TAVR  for patients at low risk for death or major complications during open-heart surgery.

As TAVR finds a new comfort zone in younger, healthier patients, determining who shouldn’t receive the replacement valve is becoming a nuanced and challenging exercise.

The transcarotid approach to TAVR is becoming more common, according to research presented at TVT.19.

The problem is fixable, but it will take hard work, says one Duke University researcher. And cardiologists could be the key. 

Proven protocols and practices, people and a push for earlier hemodynamic support are changing the face of cardiogenic shock survival. One leading health system has improved survival rates into the 70+ percent range. And their team believes other facilities should follow suit.

Artificial intelligence is emerging as a hot tool for diagnosing rhythm disorders.

Handheld POC echo has proven useful in- and outside of the emergency department, but physicians still have reservations.

CRF program planners describe how they’re building on last year’s momentum with even more practical programming.

Revolutions—dramatic and wide-reaching changes in the way something works, is organized or how we think about it—can sneak up on us.